Scarica l'app Stockscreener
302.20
1.29%
-3.96
Pre-mercato:
287.57
-14.63
-4.84%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$306.16
Aprire:
$304.4
Volume 24 ore:
1.14M
Relative Volume:
1.15
Capitalizzazione di mercato:
$21.35B
Reddito:
$3.22B
Utile/perdita netta:
$542.70M
Rapporto P/E:
40.40
EPS:
7.4805
Flusso di cassa netto:
$458.00M
1 W Prestazione:
+8.71%
1M Prestazione:
+24.18%
6M Prestazione:
+5.22%
1 anno Prestazione:
+40.85%
Intervallo 1D:
$300.31
$309.99
Intervallo di 1 settimana:
$272.13
$320.33
Portata 52W:
$202.79
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
302.20 | 21.35B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
470.99 | 166.81B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
150.22 | 42.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.23 | 38.25B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
76.01 | 37.05B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
222.02 | 32.34B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
West Pharma jumps as packaging components drive strong Q1 beat - MSN
Here's why West Pharmaceutical Services (WST) is a strong growth stock - MSN
Barclays Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $310 - Moomoo
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
WST stock jumps on Q1 earnings & sales beat, EPS view up on HVP growth - MSN
West Pharmaceutical signals 2026 revenue of $3.295B-$3.35B and adjusted EPS of $8.40-$8.75 driven by HVP components momentum - MSN
symbol__ Stock Quote Price and Forecast - CNN
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
West Pharmaceutical Services, Inc. $WST Shares Purchased by Teacher Retirement System of Texas - MarketBeat
HB Wealth Management LLC Sells 3,325 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Portillo's, West Pharmaceutical, and Oracle: Overvalued Stocks After Recent GainsNews and Statistics - IndexBox
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:WST) 2026-04-25 - Seeking Alpha
WST FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class ActionWST - TMX Newsfile
Barclays raises West Pharmaceutical price target on strong demand By Investing.com - Investing.com Nigeria
Research Alert: CFRA Raises Rating On West Pharmaceutical Services, Inc. To Buy From Hold - Moomoo
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays raises West Pharmaceutical price target on strong demand - Investing.com
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1 - Sahm
Citi Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $400 - Moomoo
West Pharmaceutical Services Q1 2026: $2.13 EPS Tops Estimates — Deep Dive - AlphaStreet
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating - marketscreener.com
A Quick Look at Today's Ratings for West Pharmaceutical Services(WST.US), With a Forecast Between $285 to $365 - Moomoo
Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating - marketscreener.com
Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating - marketscreener.com
TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating - marketscreener.com
West Pharmaceutical: A High-Quality Beat-And-Raise With More Upside Ahead - Seeking Alpha
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q1 Earnings Call Highlights - MarketBeat
West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Hig - GuruFocus
WST Earnings History & Surprises | EPS & Revenue Results | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
WST Q1 Deep Dive: High-Value Components and Operational Execution Drive Outperformance - TradingView
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom - Investing.com Australia
West Pharmaceutical: Q1 Earnings Snapshot - theheraldreview.com
West Pharma lifts 2026 profit forecast on strong demand for medical equipment - 1470 & 100.3 WMBD
West Pharmaceutical Lifts Outlook After Powerful Q1 - TipRanks
A Look at West Pharmaceutical Services Inc (WST) After 12.9% Gai - GuruFocus
BofA raises West Pharmaceutical stock price target on strong quarter By Investing.com - Investing.com Canada
TD Cowen raises West Pharmaceutical stock price target on guidance By Investing.com - Investing.com Australia
West Pharma sees plastics, elastomer demand surge with GLP-1 growth - Plastics News
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Wave - StocksToTrade
TD Cowen raises West Pharmaceutical stock price target on guidance - Investing.com
WST Stock Climbs As Dublin Expansion Targets GLP-1 Drug Boom - timothysykes.com
West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.59%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):